Three Billionaires Behind Pfizer’s Vaccine Partner BioNTech Are $2 Billion Richer After It Announces Covid-19 Vaccine Results

The announcement that the Pfizer-BioNTech vaccine could be up to 90% effective against the coronavirus led to a surge in BioNTech’s stock, adding billions to the net worths of its founder Uğur Şahin and its largest investors, Thomas and Andreas Struengmann.

Read the full post on Forbes - Healthcare